The Murphy Institute

The Murphy Institute The Murphy Institute

Health Policy

The health policy program will continue to showcase the strengths of the Murphy Institute by harnessing the expertise of the Health Policy Working Group, with the goal of producing interdisciplinary research that addresses critical healthcare policy issues. The working group has already established a network of professionals from Tulane’s uptown and downtown campuses who are beginning to collaborate on research projects.

Mary Olson is an Associate Professor of Economics at Tulane and leader of the Health Policy Working Group. Professor Olson’s teaching and research interests include health economics, the political economy of health policy, regulation, and the study of bureaucracy. She is an expert on Food and Drug Administration (FDA) regulation. Her current research interests include studying the regulatory and firm-specific determinants of drug safety.

Gultekin Gollu is the post-doctoral fellow for the Health Policy Program. He received his Ph.D. in Economics at University of Wisconsin-Madison in 2015, after completing his BA and MA in Economics in Turkey. His main research interest is on economic and health outcomes of public health policies. His recent research focuses on labor supply effects of several policy changes under the Affordable Care Act (a.k.a. Obamacare). He is also interested in other Public Health topics; one of his studies is on the internet’s effect on patients’ mental health.

Jianjing Lin is the postdoctoral fellow for the Regulation Policy Program, with a health emphasis. Originally from China, she received her Ph.D. from the University of Arizona. Her research interests include topics in Industrial Organization, Health Economics and Applied Econometrics. Her current research focuses on hospitals’ adoption of Health Information Technology (HIT). In her studies, she applies structural modeling to evaluate which IT systems hospitals use. She is also interested in how the adoption of Electronic Medical Records (EMR) impacts hospitals’ billing practices.